AstraZeneca reports 19% increase in Q1 2024 revenue to $12.67 billion
LONDON: AstraZeneca has kicked off the year with a remarkable 19% increase in Total Revenue, reaching $12.679 billion in the first quarter of 2024. The pharmaceutical giant attributes this surge to an 18% rise in Product Sales and sustained growth…